Person

Michael David Garrison

EVP & Pres Med.Essntl&BioPharm, Becton Dickinson

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$2.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 24, 2026BDXSale1,100$145.66$160K
Jun 10, 2026BDXSale1,100$151.48$167K
Jan 15, 2026BDXSale1,010$206.54$209K
Jan 15, 2026BDXSale600$209.00$125K
Dec 17, 2025BDXSale629$196.03$123K
Jul 18, 2025BDXSale1,184$180.29$213K
Jul 18, 2025BDXSale1$181.50$182
Apr 9, 2025BDXSale479$197.28$94K
Jan 17, 2025BDXSale597$236.51$141K
Dec 19, 2024BDXSale2,838$223.33$634K
Apr 30, 2024BDXSale1,715$232.81$399K
Dec 11, 2023BDXSale1,239$232.46$288K
Aug 8, 2023BDXSale1,300$277.13$360K

SEC reporting-owner ID (CIK) 1944816 · all filings on EDGAR